Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cross, H. S.
Right arrow Articles by Peterlik, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cross, H. S.
Right arrow Articles by Peterlik, M.

Growth Regulation of Human Colon Adenocarcinoma-Derived Cells by Calcium, Vitamin D and Epidermal Growth Factor1,2,

Heide S. Cross, Wolfgang Hulla, Wei-Min Tong and Meinrad Peterlik3

Department of General and Experimetnal Pathology, University of Vienna Medical School, A-1090 Vienna, Austria

The Caco-2 cell line was utilized to analyze the role of nutrient factors such as calcium, vitamin D and epidermal growth factor (EGF) in epigenetic control of human colon carcinoma cell growth. Proliferative signals from either low extracellular calcium or EGF, respectively, are transduced in Caco-2 cells via an increase in c-myc proto-oncogene mRNA and nuclear protein expression levels. Activation of the EGF receptor is associated also with down-regulation of the cytoplasmic high-affinity vitamin D receptor (VDR). This would allow colon carcinoma cells to escape from the VDR-mediated anti-mitogenic action of 1{alpha},25-dihydroxyvitamin D3 (1{alpha},25(OH)2D3). However, Caco-2 cells have the unique property to synthesize the vitamin D hormone from 25-hydroxyvitamin D3. 1{alpha},25(OH)2D3, in turn, counteracts the negative effect of EGF on VDR abundancy and slow down tumor cell proliferation through a c-myc-independent pathway.


KEY WORDS: • Caco-2 cells • Ca2+ sensitivity • 1{alpha},25-dihyhdroxyvitamin D3 • c-myc proto-oncogene • vitamin D receptor

1 Presented at the International Conference on Bone and Mineral Research held in Vienna, Austria, October 14–15, 1994. The conference was organized by the Austrian Society for Bone and Mineral Research in conjunction with the award of the 1994 Research Prize for Bone and Mineral Metabolism. The publication of conference proceedings as a supplement to The Journal of Nutrition was supported by the American Institute of Nutrition and ASTA Medica (Austria). Guest editors for this publication were Felix Bronner, University of Connecticut, Farmington, CT, and Meinrad Peterlik, University of Vienna, Vienna, Austria.

2 Investigations in the authors' laboratory referred to in this review were supported by grants from the Austrian Science Foundation (projects P 09917-MED and 10133-MED), from the Anton Dreher Memorial Fund (projects 159/90 and 184/91), as well as from the Oncology Research Fund of the University of Vienna Medical School.

3 To whom correspondence should be addressed: Department of General and Experimental Pathology, Neubau AKH, Waehringer Guertel 18–20, A-1090 Vienna, Austria.




This article has been cited by other articles:


Home page
Anticancer ResHome page
M. PETERLIK, W. B. GRANT, and H. S. CROSS
Calcium, Vitamin D and Cancer
Anticancer Res, September 1, 2009; 29(9): 3687 - 3698.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1995 by American Society for Nutrition